Concepedia

Ray Taylor

RT

Statistics

Publications

7

Citations

331

H-Index

7

Active since

2016

Affiliations

BioCryst Pharmaceuticals (United States)(Current)

Beth Israel Deaconess Medical Center

Ragon Institute of MGH, MIT and Harvard

Utah State University

Ray Taylor is an author at BioCryst Pharmaceuticals (United States) specializing in molecular virology, antiviral pharmacology, and viral infections.

ORCID

Publications per year

2016–2022

7

Publications

7

Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model

Justin G. Julander, Venkatraman Siddharthan, J. T. Evans et al. · Antiviral Research · 2016 · 164 citations · Full text

, , +11

Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters

Jonna B. Westover, Amanda Mathis, Ray Taylor et al. · Antiviral Research · 2018 · 72 citations · Full text

, , +8

A direct-acting antiviral drug abrogates viremia in Zika virus–infected rhesus macaques

So‐Yon Lim, Christa E. Osuna, Katharine Best et al. · Science Translational Medicine · 2020 · 26 citations · Full text

, , +16

Activity of Galidesivir in a Hamster Model of SARS-CoV-2

Ray Taylor, Richard A. Bowen, James F. Demarest et al. · Viruses · 2021 · 20 citations · Full text

, , +17

Galidesivir, a Direct-Acting Antiviral Drug, Abrogates Viremia in Rhesus Macaques Challenged with Zika Virus

So‐Yon Lim, Christa E. Osuna, Jessica R. Lakritz et al. · Open Forum Infectious Diseases · 2017 · 19 citations · Full text

, , +17

1–5 of 7